← Back to Clinical Trials
Recruiting NCT06249958

NCT06249958 Transforming Rehabilitation: Personalised Care for a Better Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06249958
Status Recruiting
Phase
Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Condition Osteoarthritis Secondary
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2024-01-08
Primary Completion 2024-06-30

Trial Parameters

Condition Osteoarthritis Secondary
Sponsor I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Study Type OBSERVATIONAL
Phase N/A
Enrollment 2,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2024-01-08
Completion 2024-06-30
Interventions
RehabilitationVerticalisation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

General aim of the project: building and validating an Artificial Intelligence (AI)-based prediction model on rehabilitation outcomes (total joint replacement - TJR - of the hip and knee for primary and secondary osteoarthritis) Purpose of this specific approval request: identifying data from patients admitted for total joint replacement surgery (hip and knee) at Istituto di Ricerca e Cura a Carattere Scientifico (IRCCS) Istituto Ortopedico Galeazzi (IOG) in 2019 and subsequently discharged to inpatient rehabilitation in the same institution.

Eligibility Criteria

Inclusion Criteria: * Patients admitted for inpatient surgery at IRCCS Galeazzi Orthopedic Institute in 2019 (January-December) and subsequently discharged to inpatient rehabilitation in the same structure. * Ages ≥18 years * International Classification of Disease, Ninth Revision, Clinical Modification (ICD-9CM) Diagnoses: 715.15, 16, 25, 26 (primary and secondary osteoarthritis of the hip and knee) * ICD-9CM Surgical procedures: 81.51, 81.54 (total joint replacement of the hip and knee). Exclusion Criteria: N/A

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology